The Performance of Digital Monitoring Devices for Oxygen Saturation and Respiratory Rate in COPD: A Systematic Review

Mehdipour, Ava; Wiley, Elise; Richardson, Julie; Beauchamp, Marla K.; Kuspinar, Ayse

doi:10.1080/15412555.2021.1945021

Cited by 10 publications

(6 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Besides RR, oxygen saturation,(28) heart rate,(27) spirometry,(29) and periodic assessment of symptom load are of high interest for the development of AECOPD prediction models. (30) Notably, the CSM evaluated in this study is also able to measure heart rate without contact.…”

Section: Discussionmentioning

confidence: 83%

At-home validation of remote breathing monitoring: A proof-of-concept for long-term care of respiratory patients using a non-contact, radar-based biomotion sensor

Fischer,

Eggert,

Wildenauer

et al. 2024

Preprint

View full text Add to dashboard Cite

Purpose Long-term monitoring of respiratory rate (RR) is promising for the management of chronic conditions. Research interest is particularly high in chronic respiratory diseases (CRDs), especially for predicting acute exacerbations of COPD (AECOPD). The aim of the present study was to evaluate the long-term validity of a recent non-contact biomotion sensor in the home environment of CRD patients with domiciliary ventilator support, focusing on patient acceptance and usability of this device, as well as RR fluctuations related to AECOPD. Patients and methods In this prospective proof-of-concept study, 19 patients requiring non-invasive ventilation (NIV) and seven patients requiring invasive mechanical ventilation (IMV) were provided with the non-contact device for six and one month, respectively. Main indication for NIV therapy was COPD. Real-world validation of the device was performed by comparing nocturnal RR values between the non-contact system and both types of ventilators. The acceptance and operability of the biomotion sensor were evaluated using a questionnaire. COPD exacerbations that occurred during the study period were assessed for possible RR fluctuations preceding these events. Results Mean absolute error (MAE) of median RR between the NIV device and the non-contact system, based on 2326 nights, was 0.78 (SD: 1.96) breaths per minute (brpm). MAE between the IMV device and the non-contact system was 0.12 brpm (SD: 0.52) for 215 nights. The non-contact device was accepted by the patients and proved to be easy to use. In some of the overall 13 cases of AECOPD, RR time courses showed variations of increased nocturnal respiratory activity a few days before the occurrence of such events. Conclusion The present non-contact system is suitable and well accepted for valid long-term monitoring of nocturnal RR in the patient's home environment. This finding may serve as a starting point for larger studies, e.g., to develop robust AECOPD prediction rules.

show abstract

Section: Discussionmentioning

confidence: 83%

At-home validation of remote breathing monitoring: A proof-of-concept for long-term care of respiratory patients using a non-contact, radar-based biomotion sensor

Fischer,

Eggert,

Wildenauer

et al. 2024

Preprint

View full text Add to dashboard Cite

show abstract

“…Potential items were identified by searching the literature for scientific articles and existing guidelines that describe potentially relevant reporting recommendations [ 2 , 5 , 6 , 16 , 24 – 51 ]. We applied this initial list of items to three different types of OMI systematic reviews: a systematic review of all available PROMs that measure a certain outcome domain in a certain population [ 52 ], a systematic review of one specific PROM [ 53 ], and a systematic review of a non-PROM (digital monitoring devices for oxygen saturation and respiratory rate) [ 54 ]. Application of the initial item list to these systematic reviews resulted in supporting, refuting, refining and supplementing the items.…”

Section: Methodsmentioning

confidence: 99%

Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024

Elsman,

Mokkink,

Terwee

et al. 2024

Health Qual Life Outcomes

View full text Add to dashboard Cite

Purpose Although comprehensive and widespread guidelines on how to conduct systematic reviews of outcome measurement instruments (OMIs) exist, for example from the COSMIN (COnsensus-based Standards for the selection of health Measurement INstruments) initiative, key information is often missing in published reports. This article describes the development of an extension of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guideline: PRISMA-COSMIN for OMIs 2024. Methods The development process followed the Enhancing the QUAlity and Transparency Of health Research (EQUATOR) guidelines and included a literature search, expert consultations, a Delphi study, a hybrid workgroup meeting, pilot testing, and an end-of-project meeting, with integrated patient/public involvement. Results From the literature and expert consultation, 49 potentially relevant reporting items were identified. Round 1 of the Delphi study was completed by 103 panelists, whereas round 2 and 3 were completed by 78 panelists. After 3 rounds, agreement (≥ 67%) on inclusion and wording was reached for 44 items. Eleven items without consensus for inclusion and/or wording were discussed at a workgroup meeting attended by 24 participants. Agreement was reached for the inclusion and wording of 10 items, and the deletion of 1 item. Pilot testing with 65 authors of OMI systematic reviews further improved the guideline through minor changes in wording and structure, finalized during the end-of-project meeting. The final checklist to facilitate the reporting of full systematic review reports contains 54 (sub)items addressing the review’s title, abstract, plain language summary, open science, introduction, methods, results, and discussion. Thirteen items pertaining to the title and abstract are also included in a separate abstract checklist, guiding authors in reporting for example conference abstracts. Conclusion PRISMA-COSMIN for OMIs 2024 consists of two checklists (full reports; abstracts), their corresponding explanation and elaboration documents detailing the rationale and examples for each item, and a data flow diagram. PRISMA-COSMIN for OMIs 2024 can improve the reporting of systematic reviews of OMIs, fostering their reproducibility and allowing end-users to appraise the quality of OMIs and select the most appropriate OMI for a specific application. Note In order to encourage its wide dissemination this article is freely accessible on the web sites of the journals: Health and Quality of Life Outcomes; Journal of Clinical Epidemiology; Journal of Patient-Reported Outcomes; Quality of Life Research.

show abstract

“…The comprehensive item list, containing all possible reporting items, was applied by a member of the steering committee (EE) to three existing high-quality systematic review reports: (1) a systematic review of all PROMs measuring physical functioning in type 2 diabetes, co-authored by some members of the steering committee [ 48 ]; (2) a systematic review of one specific PROM (i.e., the Dutch-Flemish PROMIS physical function item bank) [ 49 ]; and (3) a systematic review of digital monitoring devices measuring oxygen saturation and respiratory rate in COPD [ 50 ]. By applying the comprehensive item list to three different types of systematic reviews, a distinction could be made between items applicable for all review types, and items applicable to certain review types.…”

Section: Methodsmentioning

confidence: 99%

Study protocol for developing, piloting and disseminating the PRISMA-COSMIN guideline: a new reporting guideline for systematic reviews of outcome measurement instruments

et al. 2022

View full text Add to dashboard Cite

Background Systematic reviews of outcome measurement instruments are important tools in the evidence-based selection of these instruments. COSMIN (COnsensus-based Standards for the selection of health Measurement INstruments) has developed a comprehensive and widespread guideline to conduct systematic reviews of outcome measurement instruments, but key information is often missing in published reviews. This hinders the appraisal of the quality of outcome measurement instruments, impacts the decisions of knowledge users regarding their appropriateness, and compromises reproducibility and interpretability of the reviews’ findings. To facilitate sufficient, transparent, and consistent reporting of systematic reviews of outcome measurement instruments, an extension of the PRISMA (Preferred Reporting of Items for Systematic reviews and Meta-Analyses) 2020 guideline will be developed: the PRISMA-COSMIN guideline. Methods The PRISMA-COSMIN guideline will be developed in accordance with recommendations for reporting guideline development from the EQUATOR (Enhancing the QUAlity and Transparency Of health Research) Network. First, a candidate reporting item list will be created through an environmental literature scan and expert consultations. Second, an international Delphi study will be conducted with systematic review authors, biostatisticians, epidemiologists, psychometricians/clinimetricians, reporting guideline developers, journal editors as well as patients, caregivers, and members of the public. Delphi panelists will rate candidate items for inclusion on a 5-point scale, suggest additional candidate items, and give feedback on item wording and comprehensibility. Third, the draft PRISMA-COSMIN guideline and user manual will be iteratively piloted by applying it to systematic reviews in several disease areas to assess its relevance, comprehensiveness, and comprehensibility, along with usability and user satisfaction. Fourth, a consensus meeting will be held to finalize the PRISMA-COSMIN guideline through roundtable discussions and voting. Last, a user manual will be developed and the final PRISMA-COSMIN guideline will be disseminated through publications, conferences, newsletters, and relevant websites. Additionally, relevant journals and organizations will be invited to endorse and implement PRISMA-COSMIN. Throughout the project, evaluations will take place to identify barriers and facilitators of involving patient/public partners and employing a virtual process. Discussion The PRISMA-COSMIN guideline will ensure that the reports of systematic reviews of outcome measurement instruments are complete and informative, enhancing their reproducibility, ease of use, and uptake.

show abstract

The Performance of Digital Monitoring Devices for Oxygen Saturation and Respiratory Rate in COPD: A Systematic Review

Abstract: Table S1. Study characteristics of the included studies (n=7). Device Respira tion parame ter measur ed Auth or (Year ) Count ry in which the device was evalu ated Setting Sampl e size Mean age (SD)* Fem ale n (%)

Cited by 10 publications

References 32 publications

At-home validation of remote breathing monitoring: A proof-of-concept for long-term care of respiratory patients using a non-contact, radar-based biomotion sensor

At-home validation of remote breathing monitoring: A proof-of-concept for long-term care of respiratory patients using a non-contact, radar-based biomotion sensor

Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024

Study protocol for developing, piloting and disseminating the PRISMA-COSMIN guideline: a new reporting guideline for systematic reviews of outcome measurement instruments

Contact Info

Product

Resources

About